论文信息 - A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1 - 字舞流文

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1

T. File | A. Torres | M. Wilcox | T. Holland | W. O'Riordan | G. Corey | M. Dryden | Rajesh B Shukla | David B. Huang | P. McLeroth | B. Heller | J. Overcash | G. Corey | F. Amin | Rajesh Shukla | D. Huang | T. M. File | R. Shukla